David R Anderson

This inventor holds 46 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in NMDA Receptor Modulators. Top assignees: Cadent Therapeutics, Inc., Aclaris Therapeutics, Inc., Novartis Ag. Active years: 1980-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David R Anderson. Retrieved from https://idiyas.com/inventor/david-r-anderson-ii0prmqe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 46 (Patent Applications = 18)

% Patents Active = 95.7

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 11 (Patent Applications = 10)

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 192(Granted Patents)

Location History:

Delavan, WI (US) (1980)
Appleton, WI (US) (2015)
Chaska, MN (US) (2011 - 2020)
Salem, CT (US) (2017 - 2023)

Company Filing History:

13 out of 17

Cadent Therapeutics, Inc.

patents

8 out of 21

Aclaris Therapeutics, Inc.

Luc Therapeutics, Inc.

patents

8. 1 out of 1

Adaris Therapeutics, Inc.

10. 3 out of 834,601

Other

patents

Years Active: 1980-2025

Loading Chart...

Areas of Expertise:

NMDA Receptor

JAK Inhibitors

ITK Inhibitors

Bicyclic-Fused Compounds

Pyrrolopyrimidine

Thienopyrimidinone

Negative Modulators

Heteroaromatic

Cyclopenta

Substituted Pyrrolopyridines

Allosteric Modulators

Pathway Inhibitors

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12403141 - Deuterated MK2 pathway inhibitors and methods of using the same (2025-09-02),

2. 12358929 - NMDA receptor modulators and uses thereof (2025-07-15),

3. 12297203 - Pyrrolopyrimidine ITK inhibitors (2025-05-13),

4. 12281111 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2025-04-21),

5. 12202836 - Bicyclic-fused heteroaryl or aryl compounds (2025-01-21),

6. 12162890 - Heteroaromatic NMDA receptor modulators and uses thereof (2024-12-10),

7. 12161624 - Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B (2024-12-10),

8. 12145909 - N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B (2024-11-19),

9. 11820775 - Pyrrolopyrimidine ITK inhibitors (2023-11-21),

10. 11807650 - NMDA receptor modulators and uses thereof (2023-11-07),

11. 11739086 - Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same (2023-08-29),

12. 11702424 - Bicyclic-fused heteroaryl or aryl compounds (2023-07-18),

13. 11648253 - Thienopyrimidinone NMDA receptor modulators and uses thereof (2023-05-16),

14. 11542264 - Heteroaromatic NMDA receptor modulators and uses thereof (2023-01-03),

15. 11541057 - Thienopyrimidinone NMDA receptor modulators and uses thereof (2023-01-03),

Title: The Inventive Mind of David R Anderson

Introduction: David R Anderson, a talented inventor hailing from Salem, CT, has made significant contributions to the world of innovation with his creative and groundbreaking ideas.

Latest Patents: David R Anderson's latest patents showcase his ingenuity and forward-thinking approach to problem-solving. His most recent inventions focus on improving efficiency in renewable energy technologies.

Career Highlights: Throughout his illustrious career, David R Anderson has been recognized for his innovative spirit and dedication to pushing the boundaries of traditional thinking. His work has led to advancements in various industries, including sustainable energy and healthcare.

Collaborations: David R Anderson has collaborated with leading experts in the field to bring his ideas to life. His partnerships with top research institutions and companies have resulted in successful projects that have had a lasting impact on society.

Conclusion: In conclusion, David R Anderson's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor. His work continues to inspire future generations to think outside the box and strive for greatness in the world of inventions.

Profile summary based on public USPTO records.